Skip to content

Clinical trials

Anemia, Hemolytic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Hemolytic Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20131
20151
20182
20212
20221
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Enrolling by invitation2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Agios Pharmaceuticals, Inc.4
Editas Medicine, Inc.2
Forma Therapeutics, Inc.2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Archemix Corp.1
Biossil Inc.1
Boston Children's Hospital1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Hemolytic13
Anemia, Sickle Cell7
Anemia6
Hematologic Diseases6
Genetic Diseases, Inborn5
Hemoglobinopathies5
Anemia, Hemolytic, Congenital3
Hemolysis2
Sickle Cell Trait2
Thalassemia2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.